|
NRG-BR009 / OFSET
Webinars
NRG-BR009: A Phase III Adjuvant Trial Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression plus Endocrine Therapy in Premenopausal Patients with pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score ≤ 25 (OFSET)
The BR009 Protocol Leadership is planning webinars for the NRG-BR009 trial. There will be an overview of the protocol and frequently asked questions will be discussed. There will also be time for questions and answers. These webinars are intended for BR009 research staff at the sites. This is for sites that currently have NRG-BR009 open at their site, as well as those interested in opening BR009 at their site in the future.
To register to attend one of the sessions please click on the date/time you want to attend below. You will then be able to register.
If you have questions about the webinars, please contact the Clinical Coordinating Department at ccdPGH@NRGOncology.org.
| 
